Successful treatment of decompensated chronic viral hepatitis by Bursal Disease virus vaccine

Anticancer Research

Volumn 19, Issue 1 B, 1999, Pages 629-633

  Csatary, Laszlo K ^a   Schnabel, Róbert ^b   Bakács, Tibor ^c  

^a United Cancer Research Institute   (United States)

^b Nyiro Gyula Hospital   (Hungary)

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Bursal disease virus (BDV); Decompensated hepatitis; Hepatitis B virus (HBV); Hepatitis C virus (HCV); Hepatocellular carcinoma (HCC); Virus vaccine therapy

Indexed keywords

BURSAL DISEASE VIRUS VACCINE; DIURETIC AGENT; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADULT; AGED; ARTICLE; ASCITES; BIRNAVIRIDAE; CASE REPORT; CHRONIC HEPATITIS; ESOPHAGUS VARICES BLEEDING; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY FAILURE; LIVER CIRRHOSIS; PRIORITY JOURNAL; REMISSION; RNA VIRUS; SUPERINFECTION; VIRUS HEPATITIS;

ADULT; AGED; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; IMMUNOTHERAPY, ACTIVE; INFECTIOUS BURSAL DISEASE VIRUS; LIVER FUNCTION TESTS; MIDDLE AGED; RNA, VIRAL; TREATMENT OUTCOME; VACCINES, ATTENUATED; VIRAL HEPATITIS VACCINES;

EID: 0032896502     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Blumberg BS: Hepatitis B virus, the vaccine, and the control of primary cancer of the liver. Proc Natl Acad Sci USA 94: 7121-7125, 1997.
2. Galperin C and Gershwin E: Immunopathogenesis of gastro-intestinal and hepatobiliary diseases. JAMA 278: 1946-1955, 1997.
3. Hoofnagle JH and Di Bisceglie AM: The treatment of chronic viral hepatitis. N Engl J Med 336: 347-356, 1997.
4. Gitlin N, Hepatitis B: diagnosis, prevention and treatment. Clin Chem 43: 1500-1506, 1997.
5. Davis GL, Hepatitis: diagnosis and treatment. South Med J 90: 866-870, 1997.
6. Di Bisceglie AM: Hepatitis C. Lancet 351: 351-355, 1998.
7. Sharara AI: Chronic hepatitis C. South Med J 90: 872-877, 1997.
8. Lee WM: Hepatitis B virus infection. N Engl J Med 337: 1733-1745, 1997.
9. Alvarez F: Therapy for the chronic viral hepatitis. Clin Invest Med 19: 381-388, 1996.
10. Brower V: Amgen hangs hopes on hepatitis C. Nature Biothechnology 15: 1336-1337, 1997.
11. Kibens FS, Dhillon AS, Russell RG: Biochemistry of infectious bursal disease virus. J Gen Virol 69: 1757-1775, 1988.
12. Csatary KL, Telegdy L, Gergely P, Bodey B and Bakαcs T: Preliminary report of a controlled trial of MTH-68 virus vaccine treatment in acute B and C hepatitis: a phase II study. Anticane Res 18: 1279-1282, 1998.
13. Larkin M: Jay Hoofnagle: Soldiering on against viral hepatitis. Lancet 350: 938, 1997.
14. McDonnell M and Askari FK: Immunization. JAMA 278: 2000-2007, 1997.
15. Davis GL, Hoofnagle JH, Waggoner JG: Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon. J Med Virol 14: 141-147, 1984.
16. Sheen I-S, Liaw Y-F, Lin D-Y, Chu C-M: Role of hepatitis C and delta viuses in the termination of chronic heaptitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 170: 1358-1361, 1994.
17. Liaw Y-F: Role of hepatitis-C virus in dual and triple hepatitis-virus infections. Hepatology 22: 1101-1108, 1995.
18. Shih CM, Lo SJ, Miyamura T, Chen SY, and Lee YH: Suppression of hepatitis-B-virus expression and replication by hepatitis-C-virus core protein in HuH-7 cells. J Virol 67: 5823-5832, 1993.
19. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, and Alberti A: Clinical and virological profiles in patients with multiple hepatitis-virus infections. Gastroenterology 105: 1529-1533, 1993.
20. Koike K, Yasuda K, Yotsuyanagi H, Moriya K, Hino K, Kurokawa K and Iino S: Dominant replication of either virus in dual infection with hepatitis viruses B and C. J Med Virol 45: 236-239, 1995.
21. Guidotti LG, Borrow BD, Hobbs MV, Matzke B, Gresser I, Oldstone MBA, Chisari FV: Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acac Sci USA 93: 4589-4594, 1996.
22. Csatary LK, Kasza L, Massey RJ: Interference between human hepatitis A virus and an attenuated apathogenic avian virus. Acta Microbiol Hung 31: 153-158, 1984.
23. Nolan GP, Harnessing Viral Devices as Pharmaceuticals: Fighting HIV-1's Fire with Fire. Cell 90: 821-824, 1997.
24. Peterson KA, Sadasiv EC, Chang PW, Yates VJ: Detection of antibody to avian viruses in human populations. Epidemiol Infect 104: 519-525, 1990.
25. Korenman J, Baker B, Waggoner J, Everhart JE. Di Bisceglie AM and Hoofnagle JM: Long-term remission of chronic hepatitis B after alfa-interferon therapy. Annals of Internal Medicine 114: 629-634, 1991.
26. McCarthy M: Early prophylaxis may prevent HCV problems after transplantation. Lancet 350: 1228, 1997.
27. Angus PW: Review: hepatitis B and liver transplantation. J Gastroenterol Hepatol 12: 217-223, 1997.